| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And CEO | President &CEO
3 companies
Diaz Paul J serves as a President And CEO at MYGN and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $9.2M at current prices.
Historically, Diaz Paul J's trades have earned a strong insider score of 74/100 across 5 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +78.3%.
The biggest single holding is MYGN (~$9.2M) as President And CEO. The recent filings there lean toward selling, a net 257,844 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2024 | MYGN Myriad Genetics Inc | President And CEO | Sell | 15,000 | $22.93 | $343,950.00 | -1.5% | -38.4% | -68.9% | |
| Sep 11, 2024 | MYGN Myriad Genetics Inc | President And CEO | Sell | 15,000 | $26.72 | $400,800.00 | -1.5% | -41.6% | -70.8% | |
| May 15, 2024 | MYGN Myriad Genetics Inc | President And CEO | Sell | 227,844 | $25.14 | $5,728,763.31 | -17.6% | +14.3% | -83.3% | |
| May 18, 2020 | DVA Davita Inc. | Director | Sell | 5,763 | $82.22 | $473,825.07 | -36.6% | - | - |